As of Dec 31, 2024, Novartis AG's fair value using the Ben Graham formula is $429.2 per share. This is calculated using Ben Graham formula, where EPS is $5.9 and BVPS (Book Value Per Share) is $21.8. The current price of $109.4 suggests Novartis AG may be overvalued by this conservative metric.
Novartis AG earnings per share (EPS) for the twelve months ending Dec 31, 2024, was $5.9, a 38.0% growth year-over-year.
Novartis AG's margin of safety is positive 292.5%, calculated as (Graham Number - Current Price) / Current Price. A negative margin of safety suggests the stock doesn't provide the level of safety Graham typically sought in his investments.